BioLife Solutions, Inc.

BLFS

$26.30

Name : BioLife Solutions, Inc.

Sector : Healthcare

Industry: Medical Instruments & Supplies

Mark. Cap: $1,259,908,352.00

EPSttm : -0.4

BioLife Solutions, Inc.

$26.30

0.83%

$0.22

Float Short %

8.51

Margin Of Safety %

-22

Put/Call OI Ratio

0.17

EPS Next Q Diff

EPS Last/This Y

0.48

EPS This/Next Y

0.11

Price

26.28

Target Price

31.3

Analyst Recom

Performance Q

17.78

Relative Volume

Beta

1.97

Ticker: BLFS

21 items of 1

Date	Symbol	Last	P/C OI	P/C Vol	Total OI
2025-09-08	BLFS	26.22	0.14	0.00	243
2025-09-09	BLFS	26.4	0.14	0.00	243
2025-09-10	BLFS	26.48	0.14	0.00	243
2025-09-11	BLFS	26.69	0.14	0.00	244
2025-09-12	BLFS	25.5	0.14	0.00	244
2025-09-15	BLFS	25.78	0.14	0.00	244
2025-09-16	BLFS	25.96	0.14	0.00	244
2025-09-17	BLFS	25.58	0.14018691588785	0	244
2025-09-18	BLFS	26.29	0.14	0.10	245
2025-09-22	BLFS	25.24	0.14	999.99	239
2025-09-23	BLFS	24.74	0.14	999.99	239
2025-09-24	BLFS	24.23	0.17	999.99	244
2025-09-25	BLFS	24.2	0.16	0.33	243
2025-09-26	BLFS	24.69	0.16	0.33	243
2025-09-29	BLFS	24.5	0.16	1.00	242
2025-09-30	BLFS	25.52	0.16	0.00	244
2025-10-01	BLFS	26.08	0.16	0.00	245
2025-10-02	BLFS	25.91	0.16	999.99	246
2025-10-03	BLFS	26.58	0.16	999.99	246
2025-10-06	BLFS	26.48	0.16	999.99	246
2025-10-07	BLFS	26.33	0.17	0.00	247
Date	Symbol	Last	P/C OI	P/C Vol	Total OI

21 items 1 of 1

22 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-09-08	BLFS	26.22	111.4	-	0.04
2025-09-09	BLFS	26.38	111.4	-	0.04
2025-09-10	BLFS	26.50	111.4	-	0.04
2025-09-11	BLFS	26.74	111.4	-	0.04
2025-09-12	BLFS	25.50	111.4	-	0.04
2025-09-15	BLFS	25.80	111.4	-	0.04
2025-09-16	BLFS	25.98	111.4	-	0.04
2025-09-17	BLFS	25.58	111.4	-	0.04
2025-09-18	BLFS	26.28	111.4	-	0.04
2025-09-19	BLFS	25.57	111.4	-	0.04
2025-09-22	BLFS	25.28	111.4	-	0.04
2025-09-23	BLFS	24.75	111.4	-	0.04
2025-09-24	BLFS	24.11	111.4	-	0.04
2025-09-25	BLFS	24.18	111.4	-	0.04
2025-09-26	BLFS	24.70	111.4	-	0.04
2025-09-29	BLFS	24.50	111.4	-	0.04
2025-09-30	BLFS	25.54	111.4	-	0.04
2025-10-01	BLFS	26.11	111.4	-	0.04
2025-10-02	BLFS	25.93	111.4	-	0.04
2025-10-03	BLFS	26.61	111.4	-	0.04
2025-10-06	BLFS	26.50	111.4	-	0.04
2025-10-07	BLFS	26.28	111.4	-	0.04
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

22 items 1 of 1

22 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-09-08	BLFS	-54.99	5.79	8.62
2025-09-09	BLFS	-54.99	5.79	8.62
2025-09-10	BLFS	-54.99	5.79	8.62
2025-09-11	BLFS	-54.99	5.79	8.54
2025-09-12	BLFS	-54.99	5.79	8.54
2025-09-15	BLFS	-54.82	5.80	8.54
2025-09-16	BLFS	-54.82	5.80	8.54
2025-09-17	BLFS	-54.83	5.80	8.54
2025-09-18	BLFS	-54.84	5.80	8.54
2025-09-19	BLFS	-54.74	5.80	8.53
2025-09-22	BLFS	-55.30	5.80	8.53
2025-09-23	BLFS	-55.51	5.80	8.53
2025-09-24	BLFS	-55.51	5.80	8.53
2025-09-25	BLFS	-55.51	5.80	8.51
2025-09-26	BLFS	-55.51	5.80	8.51
2025-09-29	BLFS	-55.51	5.67	8.51
2025-09-30	BLFS	-55.51	5.67	8.51
2025-10-01	BLFS	-55.51	5.67	8.51
2025-10-02	BLFS	-55.51	5.67	8.51
2025-10-03	BLFS	-55.51	5.67	8.51
2025-10-06	BLFS	-54.80	7.35	8.51
2025-10-07	BLFS	-54.80	7.35	8.51
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

22 items 1 of 1

Last Quarter Act. EPS

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

0.01

Insider Transactions

-54.8

Institutional Transactions

7.35

Beta

1.97

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

20.54

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

56.7

Max Drawdown 5-Year %

-85.1

Target Price

31.3

P/E

Forward P/E

221.64

PEG

P/S

12.27

P/B

3.62

P/Free Cash Flow

107.23

EPS

-0.12

Average EPS Est. Cur. Y

0.04

EPS Next Y. (Est.)

0.15

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-5.39

Relative Volume

Return on Equity vs Sector %

-26.8

Return on Equity vs Industry %

-10.3

EPS 1 7Days Diff

EPS 1 30Days Diff

0.02

EBIT Estimation

BioLife Solutions, Inc.

Sector: Healthcare

Industry: Medical Instruments & Supplies

Employees: 159

BioLife Solutions, Inc. develops, manufactures, and markets bioproduction products and services for the cell and gene therapy (CGT) industry in the United States, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It offers proprietary biopreservation media products, including HypoThermosol FRS and CryoStor Freeze Media that are formulated to mitigate preservation-induced, delayed-onset cell damage and death; bioproduction tools, such as human platelet lysates for cell expansion and CellSeal closed system vials that are used in CGT; and the ThawSTAR line include automated thawing devices for frozen cell and gene therapies packaged in cryovials and cryobags. The company also provides evo shipping containers that are cloud-connected passive storage and transport containers for temperature-sensitive biologics and pharmaceuticals. It markets and sells its products directly, as well as through third party distributors. The company was incorporated in 1987 and is headquartered in Bothell, Washington.

stock quote shares BLFS – BioLife Solutions, Inc. Stock Price stock today

news today BLFS – BioLife Solutions, Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch BLFS – BioLife Solutions, Inc. yahoo finance google finance

stock history BLFS – BioLife Solutions, Inc. invest stock market

stock prices BLFS premarket after hours

ticker BLFS fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: BLFS

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Last Quarter Act. EPS

Average EPS Est. Cur. Y